{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:40:18Z","timestamp":1753893618283,"version":"3.41.2"},"reference-count":55,"publisher":"Sociedade Brasileira de Cardiologia","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,15]]},"DOI":"10.36660\/abc.20230405","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T16:59:44Z","timestamp":1711040384000},"source":"Crossref","is-referenced-by-count":0,"title":["Efeito Anti-Hipertensivo de Novos Agonistas do Receptor de Adenosina em Ratos Espontaneamente Hipertensos"],"prefix":"10.36660","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9006-0597","authenticated-orcid":false,"given":"Bruna","family":"de Souza Rocha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-4753","authenticated-orcid":false,"given":"Jaqueline Soares da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia Galvez Bulh\u00f5es","family":"Pedreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-0149","authenticated-orcid":false,"given":"Tadeu Lima","family":"Montagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer Jesus","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-5027","authenticated-orcid":false,"given":"Gisele","family":"Zapata-Sudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"4","key":"key20240321125938_B1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1590\/0104-1169.3345.2450","article-title":"Arterial Hypertension and Other Risk Factors Associated with Cardiovascular Diseases among Adults","volume":"22","author":"Radovanovic","year":"2014","unstructured":"1 Radovanovic CA, Santos LA, Carvalho MD, Marcon SS. Arterial Hypertension and Other Risk Factors Associated with Cardiovascular Diseases among Adults. Rev Lat Am Enfermagem. 2014;22(4):547-53. doi: 10.1590\/0104-1169.3345.2450.","journal-title":"Rev Lat Am Enfermagem"},{"issue":"10159","key":"key20240321125938_B2","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","unstructured":"2 GBD 2017 Risk Factor Collaborators. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923-94. doi: 10.1016\/S0140-6736(18)32225-6.","journal-title":"Lancet"},{"issue":"10064","key":"key20240321125938_B3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide Trends in Blood Pressure from 1975 to 2015: A Pooled Analysis of 1479 Population-Based Measurement Studies with 19\u00b71 Million Participants","volume":"389","author":"NCD Risk Factor Collaboration (NCD-RisC)]","year":"2017","unstructured":"3 NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Blood Pressure from 1975 to 2015: A Pooled Analysis of 1479 Population-Based Measurement Studies with 19\u00b71 Million Participants. Lancet. 2017;389(10064):37-55. doi: 10.1016\/S0140-6736(16)31919-5.","journal-title":"Lancet"},{"issue":"6","key":"key20240321125938_B4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies from 90 Countries","volume":"134","author":"Mills","year":"2016","unstructured":"4 Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies from 90 Countries. Circulation. 2016;134(6):441-50. doi: 10.1161\/CIRCULATIONAHA.115.018912.","journal-title":"Circulation"},{"issue":"6","key":"key20240321125938_B5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","unstructured":"5 Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-57. doi: 10.1161\/HYPERTENSIONAHA.120.15026.","journal-title":"Hypertension"},{"issue":"8","key":"key20240321125938_B6","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/HYPERTENSIONAHA.122.19564","article-title":"Hypertension 2022 Update: Focusing on the Future","volume":"79","author":"Touyz","year":"2022","unstructured":"6 Touyz RM. Hypertension 2022 Update: Focusing on the Future. Hypertension. 2022;79(8):1559-62. doi: 10.1161\/HYPERTENSIONAHA.122.19564.","journal-title":"Hypertension"},{"issue":"12","key":"key20240321125938_B7","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in Blood Pressure Control among US Adults with Hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","unstructured":"7 Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, et al. Trends in Blood Pressure Control among US Adults with Hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324(12):1190-200. doi: 10.1001\/jama.2020.14545.","journal-title":"JAMA"},{"issue":"5","key":"key20240321125938_B8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cjca.2020.02.092","article-title":"Hypertension Canada's Research and Evaluation Committee. Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women between 2007 and 2017","volume":"36","author":"Leung","year":"2020","unstructured":"8 Leung AA, Williams JVA, McAlister FA, Campbell NRC, Padwal RS; Hypertension Canada's Research and Evaluation Committee. Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women between 2007 and 2017. Can J Cardiol. 2020;36(5):732-9. doi: 10.1016\/j.cjca.2020.02.092.","journal-title":"Can J Cardiol"},{"issue":"11","key":"key20240321125938_B9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global Epidemiology, Health Burden and Effective Interventions for Elevated Blood Pressure and Hypertension","volume":"18","author":"Zhou","year":"2021","unstructured":"9 Zhou B, Perel P, Mensah GA, Ezzati M. Global Epidemiology, Health Burden and Effective Interventions for Elevated Blood Pressure and Hypertension. Nat Rev Cardiol. 2021;18(11):785-802. doi: 10.1038\/s41569-021-00559-8.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"key20240321125938_B10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.36660\/abc.20201238","article-title":"Brazilian Guidelines of Hypertension - 2020","volume":"116","author":"Barroso","year":"2021","unstructured":"10 Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brand\u00e3o AA, Feitosa ADM, et al. Brazilian Guidelines of Hypertension - 2020. Arq Bras Cardiol. 2021;116(3):516-658. doi: 10.36660\/abc.20201238.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"key20240321125938_B11","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1590\/S0100-40422002000700018","article-title":"Estrat\u00e9gia de Simplifica\u00e7\u00e3o Molecular no Planejamento Racional de F\u00e1rmacos: A Descoberta de Novo Agente Cardioativo","volume":"25","author":"Barreiro","year":"2002","unstructured":"11 Barreiro EJ. Estrat\u00e9gia de Simplifica\u00e7\u00e3o Molecular no Planejamento Racional de F\u00e1rmacos: A Descoberta de Novo Agente Cardioativo. Quim Nova. 2002;25(6):1172-80. doi: 10.1590\/S0100-40422002000700018.","journal-title":"Quim Nova"},{"issue":"3","key":"key20240321125938_B12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.bjp.0704291","article-title":"The New Compound, LASSBio 294, Increases the Contractility of Intact and Saponin-Skinned Cardiac Muscle from Wistar Rats","volume":"134","author":"Sudo","year":"2001","unstructured":"12 Sudo RT, Zapata-Sudo G, Barreiro EJ. The New Compound, LASSBio 294, Increases the Contractility of Intact and Saponin-Skinned Cardiac Muscle from Wistar Rats. Br J Pharmacol. 2001;134(3):603-13. doi: 10.1038\/sj.bjp.0704291.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"key20240321125938_B13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ajh.2010.157","article-title":"LASSBio-294, A Compound with Inotropic and Lusitropic Activity, Decreases Cardiac Remodeling and Improves Ca\u00b2(+) Influx Into Sarcoplasmic Reticulum After Myocardial Infarction","volume":"23","author":"Costa","year":"2010","unstructured":"13 Costa DG, Silva JS, K\u00fcmmerle AE, Sudo RT, Landgraf SS, Caruso-Neves C, et al. LASSBio-294, A Compound with Inotropic and Lusitropic Activity, Decreases Cardiac Remodeling and Improves Ca\u00b2(+) Influx Into Sarcoplasmic Reticulum After Myocardial Infarction. Am J Hypertens. 2010;23(11):1220-7. doi: 10.1038\/ajh.2010.157.","journal-title":"Am J Hypertens"},{"key":"key20240321125938_B14","article-title":"Planejamento, S\u00edntese e Avalia\u00e7\u00e3o Farmacol\u00f3gica de uma Nova S\u00e9rie de Derivados Cicloalquil-N-acilidrazonas: An\u00e1logos de LASSBio-294 [dissertation].","author":"Silva","year":"2012","unstructured":"14 Silva TF. Planejamento, S\u00edntese e Avalia\u00e7\u00e3o Farmacol\u00f3gica de uma Nova S\u00e9rie de Derivados Cicloalquil-N-acilidrazonas: An\u00e1logos de LASSBio-294 [dissertation]. Rio de Janeiro: Programa de P\u00f3s-gradua\u00e7\u00e3o em Qu\u00edmica, Universidade Federal do Rio de Janeiro; 2012.","journal-title":"Rio de Janeiro: Programa de P\u00f3s-gradua\u00e7\u00e3o em Qu\u00edmica, Universidade Federal do Rio de Janeiro"},{"issue":"1","key":"key20240321125938_B15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2013.11.012","article-title":"N-Acylhydrazone Improves Exercise Intolerance in Rats Submitted to Myocardial Infarction by the Recovery of Calcium Homeostasis in Skeletal Muscle","volume":"94","author":"da Silva","year":"2014","unstructured":"15 da Silva JS, Pereira SL, Maia Rdo C, Landgraf SS, Caruso-Neves C, K\u00fcmmerle AE, et al. N-Acylhydrazone Improves Exercise Intolerance in Rats Submitted to Myocardial Infarction by the Recovery of Calcium Homeostasis in Skeletal Muscle. Life Sci. 2014;94(1):30-6. doi: 10.1016\/j.lfs.2013.11.012.","journal-title":"Life Sci"},{"key":"key20240321125938_B16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/DDDT.S113289","article-title":"Adenosine A2A Receptor Agonist Prevents Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Male Rats after Myocardial Infarction","volume":"11","author":"da Silva","year":"2017","unstructured":"16 da Silva JS, Gabriel-Costa D, Sudo RT, Wang H, Groban L, Ferraz EB, et al. Adenosine A2A Receptor Agonist Prevents Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Male Rats after Myocardial Infarction. Drug Des Devel Ther. 2017;11:553-62. doi: 10.2147\/DDDT.S113289.","journal-title":"Drug Des Devel Ther"},{"key":"key20240321125938_B17","volume-title":"12\u00ba Webin\u00e1rio INCT-INOFAR online","author":"Barreiro","year":"2021","unstructured":"17 Barreiro EJ. 12\u00ba Webin\u00e1rio INCT-INOFAR online. Rio Janeiro: INCT-INOFAR; 2021 [cited 2023 Jan 4]. Video 2h27 min. Available from: https:\/\/www.youtube.com\/watch?v=GM6ZWzlbnjg."},{"issue":"3","key":"key20240321125938_B18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.36660\/abc.20201238","article-title":"Brazilian Guidelines of Hypertension - 2020","volume":"116","author":"Barroso","year":"2021","unstructured":"18 Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brand\u00e3o AA, Feitosa ADM, et al. Brazilian Guidelines of Hypertension - 2020. Arq Bras Cardiol. 2021;116(3):516-658. doi: 10.36660\/abc.20201238.","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"key20240321125938_B19","first-page":"576","article-title":"Brazilian Position Statement on Resistant Hypertension - 2020","volume":"114","author":"Yugar-Toledo","year":"2020","unstructured":"19 Yugar-Toledo JC, Moreno J\u00fanior H, Gus M, Rosito GBA, Scala LCN, Muxfeldt ES, et al. Brazilian Position Statement on Resistant Hypertension - 2020. Arq Bras Cardiol. 2020;114(3):576-96. doi: 10.36660\/abc.20200198.","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"key20240321125938_B20","doi-asserted-by":"crossref","DOI":"10.33448\/rsd-v9i11.10156","article-title":"Systemic Arterial Hypertension: Treatment with Integrative and Complementary Health Practices","volume":"9","author":"Pinheiro","year":"2020","unstructured":"20 Pinheiro IM, Montes SS, Fraga HCJR, Souza RS, Pinheiro IM, Machado AO et al. Systemic Arterial Hypertension: Treatment with Integrative and Complementary Health Practices. Res Soc Dev. 2020;9(11):e45991110156. doi: 10.33448\/rsd-v9i11.10156.","journal-title":"Res Soc Dev"},{"issue":"5","key":"key20240321125938_B21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/antiox12051005","article-title":"A Rodent Model of Human-Dose-Equivalent 5-Fluorouracil: Toxicity in the Liver, Kidneys, and Lungs","volume":"12","author":"Silva","year":"2023","unstructured":"21 Silva MC, Fabiano LC, Salom\u00e3o KCC, Freitas PLZ, Neves CQ, Borges SC, et al. A Rodent Model of Human-Dose-Equivalent 5-Fluorouracil: Toxicity in the Liver, Kidneys, and Lungs. Antioxidants. 2023;12(5):1005. doi: 10.3390\/antiox12051005.","journal-title":"Antioxidants"},{"issue":"1","key":"key20240321125938_B22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1472-8206.2012.01076.x","article-title":"Vasodilator and Antihypertensive Effects of a Novel N-Acylhydrazone Derivative Mediated by the Inhibition of L-type Ca\u00b2\u207a Channels","volume":"28","author":"Pereira","year":"2014","unstructured":"22 Pereira SL, Kummerle AE, Fraga CA, Barreiro EJ, Sudo RT, Zapata-Sudo G. Vasodilator and Antihypertensive Effects of a Novel N-Acylhydrazone Derivative Mediated by the Inhibition of L-type Ca\u00b2\u207a Channels. Fundam Clin Pharmacol. 2014;28(1):29-41. doi: 10.1111\/j.1472-8206.2012.01076.x.","journal-title":"Fundam Clin Pharmacol"},{"issue":"25","key":"key20240321125938_B23","first-page":"163","article-title":"A\u00e7\u00f5es Biol\u00f3gicas de Compostos de Sel\u00eanio e Tel\u00fario: Efeitos T\u00f3xicos sobre o Sistema Nervoso Central","volume":"25","author":"Meotti","year":"2003","unstructured":"23 Meotti FC, Nogueira CW. A\u00e7\u00f5es Biol\u00f3gicas de Compostos de Sel\u00eanio e Tel\u00fario: Efeitos T\u00f3xicos sobre o Sistema Nervoso Central. Cienc Nat. 2003;25(25):163-188. doi: 10.5902\/2179460X27244.","journal-title":"Cienc Nat"},{"issue":"10","key":"key20240321125938_B24","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1016\/j.ejmech.2009.04.044","article-title":"Studies Towards the Identification of Putative Bioactive Conformation of Potent Vasodilator Arylidene N-Acylhydrazone Derivatives","volume":"44","author":"K\u00fcmmerle","year":"2009","unstructured":"24 K\u00fcmmerle AE, Raimundo JM, Leal CM, Silva GS, Balliano TL, Pereira MA, et al. Studies Towards the Identification of Putative Bioactive Conformation of Potent Vasodilator Arylidene N-Acylhydrazone Derivatives. Eur J Med Chem. 2009;44(10):4004-9. doi: 10.1016\/j.ejmech.2009.04.044.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"key20240321125938_B25","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/ATVBAHA.118.311229","article-title":"Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension","volume":"38","author":"Brown","year":"2018","unstructured":"25 Brown IAM, Diederich L, Good ME, DeLalio LJ, Murphy SA, Cortese-Krott MM, et al. Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension. Arterioscler Thromb Vasc Biol. 2018;38(9):1969-85. doi: 10.1161\/ATVBAHA.118.311229.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"key20240321125938_B26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bjp.0704473","article-title":"Cyclic GMP-Dependent Vasodilatory Properties of LASSBio 294 in Rat Aorta","volume":"135","author":"Silva","year":"2002","unstructured":"26 Silva CL, No\u00ebl F, Barreiro EJ. Cyclic GMP-Dependent Vasodilatory Properties of LASSBio 294 in Rat Aorta. Br J Pharmacol. 2002;135(1):293-8. doi: 10.1038\/sj.bjp.0704473.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"key20240321125938_B27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.2005.099390","article-title":"The Cellular Mechanisms by Which Adenosine Evokes Release of Nitric Oxide from Rat Aortic Endothelium","volume":"570","author":"Ray","year":"2006","unstructured":"27 Ray CJ, Marshall JM. The Cellular Mechanisms by Which Adenosine Evokes Release of Nitric Oxide from Rat Aortic Endothelium. J Physiol. 2006;570(1):85-96. doi: 10.1113\/jphysiol.2005.099390.","journal-title":"J Physiol"},{"issue":"2","key":"key20240321125938_B28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150021","article-title":"Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension","volume":"11","author":"Ho","year":"2016","unstructured":"28 Ho MF, Low LM, Rose\u2019Meyer RB. Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension. PLoS One. 2016;11(2):e0150021. doi: 10.1371\/journal.pone.0150021.","journal-title":"PLoS One"},{"issue":"2","key":"key20240321125938_B29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-2999(94)90604-1","article-title":"BW-A522 Blocks Adenosine A3 Receptor-Mediated Hypotensive Responses in the Rat","volume":"252","author":"Fozard","year":"1994","unstructured":"29 Fozard JR, Hannon JP. BW-A522 Blocks Adenosine A3 Receptor-Mediated Hypotensive Responses in the Rat. Eur J Pharmacol. 1994;252(2):5-6. doi: 10.1016\/0014-2999(94)90604-1.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"key20240321125938_B30","first-page":"2076","article-title":"Species-Dependent Hemodynamic Effects of Adenosine A3-Receptor Agonists IB-MECA and Cl-IB-MECA","volume":"276","author":"Lasley","year":"1999","unstructured":"30 Lasley RD, Narayan P, Jahania MS, Partin EL, Kraft KR, Mentzer RM Jr. Species-Dependent Hemodynamic Effects of Adenosine A3-Receptor Agonists IB-MECA and Cl-IB-MECA. Am J Physiol. 1999;276(6):2076-84. doi: 10.1152\/ajpheart.1999.276.6.H2076.","journal-title":"Am J Physiol"},{"issue":"1","key":"key20240321125938_B31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0008-6363(00)00318-7","article-title":"A3 Adenosine Receptor Stimulation Modulates Sarcoplasmic Reticulum Ca(2+) Release in Rat Heart","volume":"50","author":"Zucchi","year":"2001","unstructured":"31 Zucchi R, Yu G, Ghelardoni S, Ronca F, Ronca-Testoni S. A3 Adenosine Receptor Stimulation Modulates Sarcoplasmic Reticulum Ca(2+) Release in Rat Heart. Cardiovasc Res. 2001;50(1):56-64. doi: 10.1016\/s0008-6363(00)00318-7.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"key20240321125938_B32","first-page":"228","article-title":"Adenosine A(3)-Receptor Stimulation Attenuates Postischemic Dysfunction Through K(ATP) Channels","volume":"277","author":"Thourani","year":"1999","unstructured":"32 Thourani VH, Nakamura M, Ronson RS, Jordan JE, Zhao ZQ, Levy JH, et al. Adenosine A(3)-Receptor Stimulation Attenuates Postischemic Dysfunction Through K(ATP) Channels. Am J Physiol. 1999;277(1):228-35. doi: 10.1152\/ajpheart.1999.277.1.H228.","journal-title":"Am J Physiol"},{"issue":"1","key":"key20240321125938_B33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(98)00112-6","article-title":"Selective Activation of Adenosine A3 Receptors with N6-(3-chlorobenzyl)-5\u2019-N-Methylcarboxamidoadenosine (CB-MECA) Provides Cardioprotection via KATP Channel Activation","volume":"40","author":"Tracey","year":"1998","unstructured":"33 Tracey WR, Magee W, Masamune H, Oleynek JJ, Hill RJ. Selective Activation of Adenosine A3 Receptors with N6-(3-chlorobenzyl)-5\u2019-N-Methylcarboxamidoadenosine (CB-MECA) Provides Cardioprotection via KATP Channel Activation. Cardiovasc Res. 1998;40(1):138-45. doi: 10.1016\/s0008-6363(98)00112-6.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"key20240321125938_B34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1440-1681.2002.03650.x","article-title":"Functional Roles of KATP Channels in Vascular Smooth Muscle","volume":"29","author":"Brayden","year":"2002","unstructured":"34 Brayden JE. Functional Roles of KATP Channels in Vascular Smooth Muscle. Clin Exp Pharmacol Physiol. 2002;29(4):312-6. doi: 10.1046\/j.1440-1681.2002.03650.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"key20240321125938_B35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/biomedicines9020204","article-title":"Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways","volume":"9","author":"Procopio","year":"2021","unstructured":"35 Procopio MC, Lauro R, Nasso C, Carerj S, Squadrito F, Bitto A, et al. Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways. Biomedicines. 2021;9(2):204. doi: 10.3390\/biomedicines9020204.","journal-title":"Biomedicines"},{"issue":"21","key":"key20240321125938_B36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1152\/ajpcell.1995.269.2.C519","article-title":"Adenosine Enhances Nitric Oxide Production by Vascular Endothelial Cells","volume":"269","author":"Li","year":"1995","unstructured":"36 Li JM, Fenton RA, Cutler BS, Dobson JG Jr. Adenosine Enhances Nitric Oxide Production by Vascular Endothelial Cells. Am J Physiol. 1995;269(21):519-23. doi: 10.1152\/ajpcell.1995.269.2.C519.","journal-title":"Am J Physiol"},{"issue":"3","key":"key20240321125938_B37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mad.2005.10.005","article-title":"Adenosine A(3) Receptor Mediated Coronary Vasodilation in the Rat Heart: Changes that Occur with Maturation","volume":"127","author":"Jenner","year":"2006","unstructured":"37 Jenner TL, Rose\u2019meyer RB. Adenosine A(3) Receptor Mediated Coronary Vasodilation in the Rat Heart: Changes that Occur with Maturation. Mech Ageing Dev. 2006;127(3):264-73. doi: 10.1016\/j.mad.2005.10.005.","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"key20240321125938_B38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-7258(01)00152-8","article-title":"Pharmacology of Adenosine Receptors in the Vasculature","volume":"91","author":"Tabrizchi","year":"2001","unstructured":"38 Tabrizchi R, Bedi S. Pharmacology of Adenosine Receptors in the Vasculature. Pharmacol Ther. 2001;91(2):133-47. doi: 10.1016\/s0163-7258(01)00152-8.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"key20240321125938_B39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1573403X12666160111125116","article-title":"Adenosine A3 Receptor: A Promising Therapeutic Target in Cardiovascular Disease","volume":"12","author":"Nishat","year":"2016","unstructured":"39 Nishat S, Khan LA, Ansari ZM, Basir SF. Adenosine A3 Receptor: A Promising Therapeutic Target in Cardiovascular Disease. Curr Cardiol Rev. 2016;12(1):18-26. doi: 10.2174\/1573403\u00d712666160111125116.","journal-title":"Curr Cardiol Rev"},{"issue":"4","key":"key20240321125938_B40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1152\/ajpcell.1995.268.4.C799","article-title":"Physiological Roles and Properties of Potassium Channels in Arterial Smooth Muscle","volume":"268","author":"Nelson","year":"1995","unstructured":"40 Nelson MT, Quayle JM. Physiological Roles and Properties of Potassium Channels in Arterial Smooth Muscle. Am J Physiol. 1995;268(4):799-822. doi: 10.1152\/ajpcell.1995.268.4.C799.","journal-title":"Am J Physiol"},{"key":"key20240321125938_B41","volume-title":"Participa\u00e7\u00e3o de Canais de Pot\u00e1ssio no Desenvolvimento do Processo Inflamat\u00f3rio e nas Altera\u00e7\u00f5es Cardiovasculares que ocorrem durante a Sepse\/Choque S\u00e9ptico [dissertation]","author":"Sordi","year":"2009","unstructured":"41 Sordi R. Participa\u00e7\u00e3o de Canais de Pot\u00e1ssio no Desenvolvimento do Processo Inflamat\u00f3rio e nas Altera\u00e7\u00f5es Cardiovasculares que ocorrem durante a Sepse\/Choque S\u00e9ptico [dissertation]. Florian\u00f3polis: Programa de P\u00f3s-Gradua\u00e7\u00e3o em Farmacologia, Universidade Federal de Santa Catarina; 2009."},{"issue":"3","key":"key20240321125938_B42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/molecules22030449","article-title":"Structural Probing and Molecular Modeling of the A\u2083 Adenosine Receptor: A Focus on Agonist Binding","volume":"22","author":"Ciancetta","year":"2017","unstructured":"42 Ciancetta A, Jacobson KA. Structural Probing and Molecular Modeling of the A\u2083 Adenosine Receptor: A Focus on Agonist Binding. Molecules. 2017;22(3):449. doi: 10.3390\/molecules22030449.","journal-title":"Molecules"},{"issue":"12","key":"key20240321125938_B43","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.3390\/molecules27123680","article-title":"Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data","volume":"27","author":"Fishman","year":"2022","unstructured":"43 Fishman P. Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data. Molecules. 2022;27(12):3680. doi: 10.3390\/molecules27123680.","journal-title":"Molecules"},{"issue":"3","key":"key20240321125938_B44","first-page":"552","article-title":"Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on Angiotensin Converting Enzyme in Vitro and Angiotensin I Pressor Responses in Vivo","volume":"216","author":"Gross","year":"1981","unstructured":"44 Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, et al. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on Angiotensin Converting Enzyme in Vitro and Angiotensin I Pressor Responses in Vivo. J Pharmacol Exp Ther. 1981;216(3):552-7.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"key20240321125938_B45","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00004872-199507001-00002","article-title":"Pharmacology of Losartan, an Angiotensin II Receptor Antagonist, in Animal Models of Hypertension","volume":"13","author":"Siegl","year":"1995","unstructured":"45 Siegl PK, Kivlighn SD, Broten TP. Pharmacology of Losartan, an Angiotensin II Receptor Antagonist, in Animal Models of Hypertension. J Hypertens Suppl. 1995;13(1):S15-21. doi: 10.1097\/00004872-199507001-00002.","journal-title":"J Hypertens Suppl"},{"issue":"3","key":"key20240321125938_B46","first-page":"1","article-title":"7th Brazilian Guideline of Arterial Hypertension: Presentation","volume":"107","author":"Malachias","year":"2016","unstructured":"46 Malachias MV, Souza WKSB, Plavnik FL, Rodrigues CIS, Brand\u00e3o AA, Neves MFT, et al. 7th Brazilian Guideline of Arterial Hypertension: Presentation. Arq Bras Cardiol. 2016;107(3 Suppl 3):1-103. doi: 10.5935\/abc.20160140.","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"key20240321125938_B47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6107(02)00053-6","article-title":"Physiological and Pathophysiological Roles of ATP-Sensitive K+ Channels","volume":"81","author":"Seino","year":"2003","unstructured":"47 Seino S, Miki T. Physiological and Pathophysiological Roles of ATP-Sensitive K+ Channels. Prog Biophys Mol Biol. 2003;81(2):133-76. doi: 10.1016\/s0079-6107(02)00053-6.","journal-title":"Prog Biophys Mol Biol"},{"issue":"15","key":"key20240321125938_B48","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2174\/1381612054021015","article-title":"ATP-Sensitive Potassium Channels","volume":"11","author":"Rodrigo","year":"2005","unstructured":"48 Rodrigo GC, Standen NB. ATP-Sensitive Potassium Channels. Curr Pharm Des. 2005;11(15):1915-40. doi: 10.2174\/1381612054021015.","journal-title":"Curr Pharm Des"},{"issue":"10","key":"key20240321125938_B49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5483\/BMBRep.2018.51.10.098","article-title":"LJ-1888, a Selective Antagonist for the A3 Adenosine Receptor, Ameliorates the Development of Atherosclerosis and Hypercholesterolemia in Apolipoprotein E knock-out Mice","volume":"51","author":"Park","year":"2018","unstructured":"49 Park JG, Jeong SJ, Yu J, Kim G, Jeong LS, Oh GT. LJ-1888, a Selective Antagonist for the A3 Adenosine Receptor, Ameliorates the Development of Atherosclerosis and Hypercholesterolemia in Apolipoprotein E knock-out Mice. BMB Rep. 2018;51(10):520-5. doi: 10.5483\/BMBRep.2018.51.10.098.","journal-title":"BMB Rep"},{"key":"key20240321125938_B50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic Signalling: Therapeutic Developments","volume":"8","author":"Burnstock","year":"2017","unstructured":"50 Burnstock G. Purinergic Signalling: Therapeutic Developments. Front Pharmacol. 2017;8:661. doi: 10.3389\/fphar.2017.00661.","journal-title":"Front Pharmacol"},{"issue":"1","key":"key20240321125938_B51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tips.2021.10.010","article-title":"Adenosine and Inflammation: It\u2019s Time to (re)solve the Problem","volume":"43","author":"Antonioli","year":"2022","unstructured":"51 Antonioli L, Pacher P, Hask\u00f3 G. Adenosine and Inflammation: It\u2019s Time to (re)solve the Problem. Trends Pharmacol Sci. 2022;43(1):43-55. doi: 10.1016\/j.tips.2021.10.010.","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"key20240321125938_B52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/acsptsci.2c00076","article-title":"Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators that Preferentially Enhance Adenosine-Induced G\u03b1i3 and G\u03b1oA Isoprotein Activation","volume":"5","author":"Fisher","year":"2022","unstructured":"52 Fisher CL, Fallot LB, Wan TC, Keyes RF, Suresh RR, Rothwell AC, et al. Characterization of Dual-Acting A3 Adenosine Receptor Positive Allosteric Modulators that Preferentially Enhance Adenosine-Induced G\u03b1i3 and G\u03b1oA Isoprotein Activation. ACS Pharmacol Transl Sci. 2022;5(8):625-41. doi: 10.1021\/acsptsci.2c00076.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"key20240321125938_B53","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.01.018","article-title":"A(3) Adenosine Receptor Activation During Reperfusion Reduces Infarct Size Through Actions on Bone Marrow-Derived Cells","volume":"49","author":"Ge","year":"2010","unstructured":"53 Ge ZD, van der Hoeven D, Maas JE, Wan TC, Auchampach JA. A(3) Adenosine Receptor Activation During Reperfusion Reduces Infarct Size Through Actions on Bone Marrow-Derived Cells. J Mol Cell Cardiol. 2010;49(2):280-6. doi: 10.1016\/j.yjmcc.2010.01.018.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"key20240321125938_B54","first-page":"H1895","article-title":"A(3) Adenosine Receptor Activation Attenuates Neutrophil Function and Neutrophil-Mediated Reperfusion Injury","volume":"277","author":"Jordan","year":"1999","unstructured":"54 Jordan JE, Thourani VH, Auchampach JA, Robinson JA, Wang NP, Vinten-Johansen J. A(3) Adenosine Receptor Activation Attenuates Neutrophil Function and Neutrophil-Mediated Reperfusion Injury. Am J Physiol. 1999;277(5):H1895-905. doi: 10.1152\/ajpheart.1999.277.5.H1895.","journal-title":"Am J Physiol"},{"issue":"3","key":"key20240321125938_B55","first-page":"203","article-title":"I Brazilian Position Paper on Antihypertensive Drug Combination","volume":"102","author":"P\u00f3voa","year":"2014","unstructured":"55 P\u00f3voa R, Barroso WS, Brand\u00e3o AA, Jardim PC, Barroso O, Passarelli O Jr, et al. I Brazilian Position Paper on Antihypertensive Drug Combination. Arq Bras Cardiol. 2014;102(3):203-10. doi: 10.5935\/abc.20140023.","journal-title":"Arq Bras Cardiol"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/efeito-anti-hipertensivo-de-novos-agonistas-do-receptor-de-adenosina-em-ratos-espontaneamente-hipertensos\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:01:26Z","timestamp":1747400486000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/efeito-anti-hipertensivo-de-novos-agonistas-do-receptor-de-adenosina-em-ratos-espontaneamente-hipertensos\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3,15]]}},"alternative-id":["10.36660\/abc.20230405"],"URL":"https:\/\/doi.org\/10.36660\/abc.20230405","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e20230405"}}